Literature DB >> 7021123

Adverse effects of antihypertensive drugs.

F E Husserl, F H Messerli.   

Abstract

Early essential hypertension is asymptomatic and should remain so throughout treatment. In view of the increasing number of available antihypertensive agents, clinicians need to become familiar with the potential side effects of these drugs. By placing more emphasis on non-pharmacological treatment (sodium restriction, weight loss, exercise) and thoroughly evaluating each case in particular, the pharmacological regimen can be optimally tailored to the patient's needs. Potential side effects should be predicted and can often be avoided; if they become clinically significant they should be rapidly recognised and corrected. These side effects can be easily remembered in most instances, as they fall into 3 broad categories: (a) those caused by an exaggerated therapeutic effect; (b) those due to a non-therapeutic pharmacological effect; and (c) those caused by a non-therapeutic, non-pharmacological effect probably representing idiosyncratic reactions. This review focuses mainly on adverse effects of the second and third kind. Each group of drugs in general shares the common side effects of the first two categories, while each individual drug has its own idiosyncratic side effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021123     DOI: 10.2165/00003495-198122030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  170 in total

1.  A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).

Authors:  H J Keim; J I Drayer; D B Case; J Lopez-Ovejero; J M Wallace; M A Weber; J H Laragh
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

2.  Long-term use of prazosin in combination or alone for treating hypertension.

Authors:  G S Stokes; J M Gain; J F Mahony; J Raftos; J H Stewart
Journal:  Med J Aust       Date:  1977-08-20       Impact factor: 7.738

3.  Effects on the neonate of propranolol administered during pregnancy.

Authors:  A Habib; J S McCarthy
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

4.  Sympathetic nervous system blocking in hyperthyroidism.

Authors:  A I Vinik; B L Pimstone; R Hoffenberg
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

5.  Clinical response to long-term propranolol therapy in hyperthyroidism.

Authors:  B Pimstone; B Joffe; N Pimstone; F Bonnici; W P Jackson
Journal:  S Afr Med J       Date:  1969-09-27

6.  Comparison of the antihypertensive effectiveness of guanadrel and guanethidine.

Authors:  S G Chrysant; E D Frohlich
Journal:  Curr Ther Res Clin Exp       Date:  1976-03

7.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

8.  Scalp tingling in patients on labetalol.

Authors:  A S Hua; G W Thomas; P Kincaid-Smith
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

Review 9.  Minoxidil.

Authors:  B Canaday
Journal:  South Med J       Date:  1980-01       Impact factor: 0.954

10.  Study of a new antihypertensive (guanabenz).

Authors:  F G McMahon; P A Cole; P W Boyles; S K Vanov
Journal:  Curr Ther Res Clin Exp       Date:  1974-05
View more
  10 in total

1.  Ketanserin in the treatment of diabetes-associated hypertension.

Authors:  C Beretta-Piccoli
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  The effects of two centrally-acting anti-hypertensive drugs on the quality of life.

Authors:  A E Fletcher; D G Beevers; C T Dollery; R Wilkinson; C J Bulpitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.

Authors:  L Alcocer; C Campos; J H Bahena; A Nacaud; J Parra Carillo; C Calvo; C Weber; G Lerebours; L Mickalonis; M T Villahermosa
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

4.  Accurate Prediction of Anti-hypertensive Peptides Based on Convolutional Neural Network and Gated Recurrent unit.

Authors:  Hongyan Shi; Shengli Zhang
Journal:  Interdiscip Sci       Date:  2022-04-27       Impact factor: 3.492

5.  Blood Pressure Modulation With Low-Intensity Focused Ultrasound Stimulation to the Vagus Nerve: A Pilot Animal Study.

Authors:  Ning Ji; Wan-Hua Lin; Fei Chen; Lisheng Xu; Jianping Huang; Guanglin Li
Journal:  Front Neurosci       Date:  2020-11-12       Impact factor: 4.677

6.  Nifedipine in the treatment of difficult hypertensives.

Authors:  S Dean; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

Review 8.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

9.  Anti-hypertensive Effects of Artichoke Supplementation in Adults: A Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials.

Authors:  Mohammad Reza Amini; Fatemeh Sheikhhossein; Mohsen Alvani; Seyyed Morteza Seyyed Shoura; Asma Sohrabnavi; Ehsan Heidarian; Azita Hekmatdoost
Journal:  Clin Nutr Res       Date:  2022-07-26

10.  Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs.

Authors:  Xiaojiang Qin; Xiaomin Hou; Mingsheng Zhang; Taigang Liang; Jianmin Zhi; Lingge Han; Qingshan Li
Journal:  Int J Mol Sci       Date:  2014-04-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.